A little more than a month after AstraZeneca jumped into the fray with the purchase of a rival heart drug candidate, Eli ...

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, ...

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

The combination of sacubitril and valsartan reduces the cardiotoxicity related to anthracycline chemotherapy drugs, according ...

Stress after a heart attack is understandable – and new research into what drives such stress suggests that fear of another heart attack might play a significant role. Understanding how that fear ...

Ablation, a procedure to treat abnormal electrical short circuits caused by a heart attack and is usually reserved for ...

A study found that undergoing a cardiac ablation procedure first—before taking any antiarrhythmic therapies—may be the better ...

Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

A study from the University of Edinburgh has revealed that long-term use of paracetamol might increase the risk of heart ...

The medication was generally well tolerated ... including blood testing and specialized heart testing with echocardiography and cardiac MRI (magnetic resonance imaging) for six months to assess heart ...

A recent study has found that a medication commonly used to treat high blood pressure could increase the risk of sudden cardiac arrest (SCA). This discovery has led experts to advise caution when ...